Lake Street analyst <a data-cke-saved-href="https://www.tipranks.com/experts/analysts/brooks-o?utm_source=markets.businessinsider.com&utm_medium=referral" href="https://www.tipranks.com/experts/analysts/brooks-o?utm_source=markets.businessinsider.com&utm_medium=referral" neil'="" target="_blank" rel="nofollow" style="box-sizing: border-box; background-color: initial; color: blue; text-decoration-line: none; font-weight: bold;">Brooks O’Neil assigned a Buy rating to Viemed Healthcare (VMD – Research Report) today and set a price target of $15.00. The company’s shares closed yesterday at $7.18.
O’Neil covers the Healthcare sector, focusing on stocks such as Avita Medical, Tandem Diabetes Care, and Augmedix. According to TipRanks, O’Neil has an average return of 0.4% and a 42.91% success rate on recommended stocks.
Currently, the analyst consensus on Viemed Healthcare is a Moderate Buy with an average price target of $15.00.
The company has a one-year high of $10.44 and a one-year low of $5.90. Currently, Viemed Healthcare has an average volume of 153.2K.